JPH03285653A - Fat metabolism improving substance and production thereof - Google Patents
Fat metabolism improving substance and production thereofInfo
- Publication number
- JPH03285653A JPH03285653A JP2083766A JP8376690A JPH03285653A JP H03285653 A JPH03285653 A JP H03285653A JP 2083766 A JP2083766 A JP 2083766A JP 8376690 A JP8376690 A JP 8376690A JP H03285653 A JPH03285653 A JP H03285653A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- grain
- gum
- glucan
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000000126 substance Substances 0.000 title abstract description 9
- 230000004060 metabolic process Effects 0.000 title abstract 3
- 235000013339 cereals Nutrition 0.000 claims abstract description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 16
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 11
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 11
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 10
- 239000000243 solution Substances 0.000 claims abstract description 10
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 5
- 239000003513 alkali Substances 0.000 claims abstract description 4
- 239000003456 ion exchange resin Substances 0.000 claims abstract description 4
- 229920003303 ion-exchange polymer Polymers 0.000 claims abstract description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 240000005979 Hordeum vulgare Species 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 18
- 235000007319 Avena orientalis Nutrition 0.000 claims description 15
- 230000037356 lipid metabolism Effects 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 244000075850 Avena orientalis Species 0.000 claims description 6
- 230000005856 abnormality Effects 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000000909 electrodialysis Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 241000209140 Triticum Species 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 4
- 230000007935 neutral effect Effects 0.000 claims 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims 2
- 229930182830 galactose Natural products 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 230000009965 odorless effect Effects 0.000 claims 2
- 230000009967 tasteless effect Effects 0.000 claims 2
- 229920001503 Glucan Polymers 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000002244 precipitate Substances 0.000 abstract description 5
- 235000013312 flour Nutrition 0.000 abstract description 4
- 238000011033 desalting Methods 0.000 abstract description 3
- 235000020985 whole grains Nutrition 0.000 abstract description 3
- 238000001035 drying Methods 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 150000007524 organic acids Chemical class 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- 238000001962 electrophoresis Methods 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 16
- 241000209219 Hordeum Species 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 235000013325 dietary fiber Nutrition 0.000 description 12
- 239000002994 raw material Substances 0.000 description 11
- 241000209761 Avena Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 235000000891 standard diet Nutrition 0.000 description 4
- 235000007558 Avena sp Nutrition 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 208000035150 Hypercholesterolemia Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000006371 metabolic abnormality Effects 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 229940098396 barley grain Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000003636 fecal output Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- BBJIPMIXTXKYLZ-UHFFFAOYSA-N isoglutamic acid Chemical compound OC(=O)CC(N)CC(O)=O BBJIPMIXTXKYLZ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 239000001912 oat gum Substances 0.000 description 1
- 235000019313 oat gum Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 238000011684 zucker rat (obese) Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
産業上辺上]冴夏
本発明は、オーツ麦、大麦等の穀物から抽出精製された
β−グルカンを主成分とずろ新規なガム質及びその製造
法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Topics] Saekatsu The present invention relates to a novel gum quality whose main component is β-glucan extracted and purified from grains such as oats and barley, and a method for producing the same.
さらに、本発明は、このような新規ガム質を有効成分と
する脂質代謝改善物に関する。Furthermore, the present invention relates to a lipid metabolism improving product containing such a novel gum substance as an active ingredient.
技′i酌狂罰激
食物繊維は1.ヒトの消化酵素で消化されない食物中の
難消化性成分であり、その中には、セルロース、ヘミセ
ルロース、リグニン、水溶性及び水不溶性べ/7チン質
、粘質物(β−グルカン、ガラク17.′ナン、グルコ
フンナ、1等)、海藻多糖類、\
化−L澱粉、カルボキンメチルセルロース等が含マれる
。食物繊維はその性質から水?8性と水不溶性とに大別
され、水溶性食物繊維は、(1)腸内に存在する有害物
質あるいは発癌性物質の吸収を阻害し、tJP?tQす
る。(2)コレステロール、胆汁酸、重金属を吸着して
排泄する。(3)腸内細菌這を有用菌優位として、腸の
環境をよくする等の生理作用が認められている。一方、
水不溶性食物繊維は、(1)腸の螺動運動を高め、食物
の腸内通過時間を短縮する、(2)腸内客用゛及び糞便
量を増大する等の生理作用が認められている。Tech'i Drunken Punishment Fierce Dietary Fiber is 1. Indigestible components in food that are not digested by human digestive enzymes, including cellulose, hemicellulose, lignin, water-soluble and water-insoluble betatin, mucilage (β-glucan, galac). These include naan, glucofunna, 1 etc.), seaweed polysaccharides, \-L starch, carboquine methyl cellulose, etc. Is dietary fiber water due to its nature? Water-soluble dietary fiber is broadly classified into 8 types and water-insoluble.Water-soluble dietary fiber (1) inhibits the absorption of harmful substances or carcinogenic substances present in the intestines, and tJP? Do tQ. (2) Adsorbs and excretes cholesterol, bile acids, and heavy metals. (3) It has been recognized that it has physiological effects such as improving the intestinal environment by making intestinal bacteria predominant as useful bacteria. on the other hand,
Water-insoluble dietary fiber has been recognized to have physiological effects such as (1) increasing intestinal spiral movement and shortening the time taken for food to pass through the intestines, and (2) increasing intestinal circulation and fecal volume. .
また、穀物、特にその一種であるオーツ麦ならびに大麦
は蛋白質や脂質、ミネラルに冨むだけでなく、食物繊維
を多く含んでいる。オーツ麦と大麦には水溶性食物繊維
と水不溶性食物繊維がバランスよく含まれ、水溶性食物
繊維はβ−グルカンを主成分とする穀物ガム質である。In addition, grains, particularly oats and barley, are not only rich in protein, fat, and minerals, but also contain a large amount of dietary fiber. Oats and barley contain a good balance of water-soluble dietary fiber and water-insoluble dietary fiber, and the water-soluble dietary fiber is a grain gum whose main component is β-glucan.
発馴ガ邂伏↓λj2−す用
本発明者らは、上記穀物ガム質とはどのようなものであ
るかについて鋭意研究を重ね、上記穀物ガム質を具体的
に採取する方法を確立し、穀物ガム質Gこついて解明し
、さらに穀物ガム質を摂取することにより脂質代謝異常
、特に遺伝的な脂質代謝異常の症状を改善することがで
きることを見出し、本発明を完成するに至−たものであ
る。The inventors of the present invention have conducted extensive research into what the grain gum is, and have established a method for specifically collecting the grain gum. We have elucidated the problem of grain gum G and further discovered that by ingesting grain gum, it is possible to improve the symptoms of lipid metabolism abnormalities, especially genetic lipid metabolism abnormalities, and have completed the present invention. It is.
すなわち、本発明の課題は、穀物、特にオーツ麦、大麦
から得られるβ−グルカンを主成分とする穀物ガムも及
びその製造法を提供することにある。That is, an object of the present invention is to provide a grain gum containing β-glucan obtained from grains, particularly oats and barley, as a main component, and a method for producing the same.
さらに、本発明の課題は、このような穀物ガム質を有効
成分とする脂質代謝改善物を提(Jjすることにある。Furthermore, an object of the present invention is to provide a lipid metabolism improving product containing such grain gum as an active ingredient.
課題に邂快−tゑ妻悌勿]我−
本発明は、上記課題を達成するためになされたものであ
って、穀物を原料とし、これをアルカリ水溶液によって
抽出し、抽出液を酸性にして蛋白質を沈澱除去したのち
、残液にアルコールを加えて沈澱させる、あるいは、限
外濾過、電気透析、イオン交換樹脂のいずれかによって
脱塩後、乾燥させて得ることができるβ−グルカンを主
成分とする穀物ガム質及びその製造法に関する。The present invention has been made to achieve the above-mentioned problems, and uses grain as a raw material, extracts it with an alkaline aqueous solution, and makes the extract acidic. The main component is β-glucan, which can be obtained by precipitating and removing proteins, then adding alcohol to the residual solution to precipitate it, or desalting it by ultrafiltration, electrodialysis, or ion exchange resin, and then drying it. This article relates to grain gum and its manufacturing method.
本発明における原料の穀物としては、小麦、大麦、燕麦
、オーツ麦、はと麦、ライ麦等の麦類、米、ひえ、あわ
等があるが、特に大麦及びオーツ麦が、食物繊維を多く
含み、かつ、水溶性食物繊維と水不溶性食物繊維とがバ
ランス良く含まれているので原料として望ましい。Grains used as raw materials in the present invention include wheat, barley, oats, oats, barley such as rye, rice, millet, and millet, but barley and oats are particularly rich in dietary fiber. Moreover, it is desirable as a raw material because it contains water-soluble dietary fiber and water-insoluble dietary fiber in a well-balanced manner.
使用するオーツ麦または大麦は、全粒粉あるいは精白扮
を用いるとよい。ごれらの原料のアルカリ性水溶性によ
る抽出は、原料に水を加え、これにアルカリ水溶液を加
えてアルカリ性として加温下に撹拌して抽出する。It is best to use whole grain or refined oats or barley. Extraction of the raw materials for Gorera using alkaline water solubility involves adding water to the raw materials, adding an alkaline aqueous solution to the raw materials to make the raw materials alkaline, and stirring and extracting under heating.
アルカリとしては苛性ソーダ、苛性カリ、炭酸すl・リ
ウム等が用いられ、抽出液をp119〜11程度のアル
カリ性とし、40〜50゛C前後に撹拌下に加温して数
十分乃至1時間前後抽出する。このようにすると、本発
明の穀物ガム質が抽出され、抽出液中に移行する。As the alkali, caustic soda, caustic potash, sulfur/lium carbonate, etc. are used, and the extract is made alkaline to about 119 to 11, heated to around 40 to 50°C with stirring, and extracted for about several tens of minutes to an hour. do. In this way, the grain gum of the present invention is extracted and transferred into the extract.
この抽出液を濾別あるいは遠心分離によって抽出液と残
渣とに分離し、抽出液を採取する。This extract is separated into an extract and a residue by filtration or centrifugation, and the extract is collected.
次に、抽出液を酸性にして蛋白質を沈澱除去し残液を採
取する。Next, the extract is acidified to remove proteins by precipitation, and the remaining liquid is collected.
抽出液の酸性への移行は、抽出液に塩酸、硫酸等の無機
酸あるいはクエン酸等の有機酸の水溶液を加え、抽出液
のpHを蛋白質の等電点であるpH4,5イ]近に調整
することによって行う。このようにすると蛋白質が沈澱
されて除去される。To make the extract acidic, add an aqueous solution of an inorganic acid such as hydrochloric acid or sulfuric acid or an organic acid such as citric acid to the extract to bring the pH of the extract close to pH 4.5, which is the isoelectric point of the protein. Do this by adjusting. In this way, proteins are precipitated and removed.
この抽出液を濾別あるいは遠心分離することによって濾
液あるいは上澄液を採取する。A filtrate or supernatant is collected by filtering or centrifuging this extract.
これらの残液を、約数分の1量まで濃縮する。These residual liquids are concentrated to about a fraction of their volume.
通常、この濃縮は、減圧濃縮または限外濾過によって行
う。Usually, this concentration is carried out by vacuum concentration or ultrafiltration.
そして、この濃縮液にアルコールを加えて沈澱を生じさ
せ、この沈澱を採取する。アルコールはイソプロパツー
ル、エタノール等のアルコールが用いられるが、エタノ
ールを用いることが食品衛生上から望ましい。Then, alcohol is added to this concentrated solution to form a precipitate, and this precipitate is collected. As the alcohol, alcohols such as isopropanol and ethanol are used, but it is preferable to use ethanol from the viewpoint of food hygiene.
得られる沈澱は、β−グルカンを主成分とする穀物ガム
質であって、これを数回アルコール、特にエタノールに
よって洗滌し、乾燥、粉砕して穀物ガム質を得る。ある
いは、濃縮液を分画分子量数万の限外濾過、電気透析、
イオン交換樹脂のいずれかによって脱塩したのち、乾燥
、粉砕して、上記穀物ガム質を得る。The resulting precipitate is a grain gum containing β-glucan as a main component, and this is washed several times with alcohol, especially ethanol, dried and ground to obtain a grain gum. Alternatively, the concentrated solution may be subjected to ultrafiltration with a molecular weight cut-off of tens of thousands, electrodialysis,
After desalting using any of the ion exchange resins, the grains are dried and crushed to obtain the above-mentioned grain gum.
さらに、本発明は、このようにして得られた穀物ガム質
を有効成分とする脂質代謝改善物に関する。Furthermore, the present invention relates to a lipid metabolism improving product containing the grain gum thus obtained as an active ingredient.
本発明では、前記穀物ガム質を遺伝性肥満ラントを試験
動物として用い、脂質代謝異常の改善効果を調べた。そ
の結果、後述するように高コレステロール血症改善効果
、脂肪肝抑制効果があり、脂質代謝異常を改善すること
ができることが判明した。In the present invention, the effect of improving lipid metabolism abnormalities was investigated using the above-mentioned grain gum in genetically obese runts as test animals. As a result, it was found that it has a hypercholesterolemia-improving effect, a fatty liver suppressing effect, and can improve lipid metabolic abnormalities, as described below.
本発明では、脂質代謝異常を、薬剤の投与によって緩和
するのでなく、食事中に少量配合することによって改善
することができる。In the present invention, lipid metabolic abnormalities can be improved not by administering a drug, but by incorporating a small amount of the drug into a meal.
本発明における配合量は、成人1日当り上記穀物ガム質
粉末1〜5g程度が好ましい。これは、食事、例えば炊
飯時の炊飯や味噌汁等に配合したりあるいはスープ中に
配合して経口的に投与するとよい。また、キャンデー等
に含有させたり、あるいは乳糖等と混合して錠剤に成型
して投与してもよい。The blending amount in the present invention is preferably about 1 to 5 g of the grain gummy powder per adult per day. This is preferably administered orally by adding it to a meal, such as cooking rice or miso soup, or adding it to a soup. It may also be administered by incorporating it into candy or the like, or by mixing it with lactose or the like and forming it into a tablet.
本発明について実施例を挙げて具体的に説明する。The present invention will be specifically described with reference to Examples.
実施■土
全粒オーツ麦粉ならびに精白大麦粉(精白歩留73%)
を原料として用いた。これらの原料の成分組成を第1表
に示す。Implementation ■ Whole grain oat flour and refined barley flour (refined yield 73%)
was used as the raw material. The compositions of these raw materials are shown in Table 1.
Asp法にて分析。Analyzed by Asp method.
これらの原料から穀物ガム質標品の調製は以下の手順で
行った。各原料6kgに水30℃を加え、炭酸ナト1ノ
ウム20%溶液を添加してρ1110に調整したのち、
45°Cにて30分間撹拌抽出した。Grain gum quality samples were prepared from these raw materials according to the following procedure. Add water at 30°C to 6 kg of each raw material, add a 20% solution of sodium carbonate, and adjust to ρ1110.
Extraction was carried out with stirring at 45°C for 30 minutes.
抽出液を6000rpmの遠心力を利用したデカンタ−
にて固液分離して回収し、さらに残渣を同し方法0
で2回抽出して、抽出液を回収した。A decanter that uses centrifugal force at 6000 rpm to collect the extract.
The residue was extracted twice using the same method 0, and the extract was collected.
次に、抽出液に2M塩酸を加えpH4,5に調整して蛋
白質画分を沈澱させたのち、17000Gの遠心力を利
用した連続遠心分離機にて固液分離して、上澄液を回収
した。この上澄液をロータリー・エハポレクーを用いて
115量まで減圧濃縮したのち、4倍量のエタノールを
加えて、穀物ガム質を主成分とする多糖画分を沈澱させ
た。さらに、多糖画分をエタノール10I!、で洗浄し
通風乾燥、粉砕して穀物ガム質標品とした。 回収され
たオーツ麦ならびに大麦ガム質標品はそれぞれ200g
、180gであった。Next, 2M hydrochloric acid was added to the extract to adjust the pH to 4.5 to precipitate the protein fraction, followed by solid-liquid separation in a continuous centrifuge using 17,000 G centrifugal force, and the supernatant was collected. did. This supernatant was concentrated under reduced pressure using a rotary elevator to a volume of 115, and then 4 times the amount of ethanol was added to precipitate a polysaccharide fraction containing grain gum as the main component. Furthermore, the polysaccharide fraction was added to ethanol 10I! The grains were washed, dried with ventilation, and crushed to obtain a grain gum quality specimen. 200g each of recovered oat and barley gum quality samples
, 180g.
これらの穀物ガム質の成分組成を第2表に示す。The composition of these grain gums is shown in Table 2.
第2表 穀類ガム質成分組成 (乾物%) *Asp法にて分析。Table 2 Grain gum component composition (Dry matter%) *Analyzed using the Asp method.
易謙l舛
次に各穀物ガム質を遺伝性肥満ラットを試験動物として
脂質代謝異常の改善効果を調べた。Next, the effects of each grain gum on improving lipid metabolism abnormalities were investigated using genetically obese rats as test animals.
実験動物としてZucker系の遺伝性肥満ラット並び
に正常ラット(共に雄、6退会)を用い、オーツ麦なら
びに大麦の穀物ガム質標品を飼料に配合し、第3表に示
した組成の飼料を調製した。各実験飼料を遺伝性肥満ラ
ットに1群8匹として34日1
2
間投与した。また、正常ラット7匹に標準飼料を同一期
間投与した。Using genetically obese Zucker rats and normal rats (both male, withdrawn from membership at age 6) as experimental animals, oat and barley grain gum quality samples were added to the feed to prepare feed with the composition shown in Table 3. did. Each experimental diet was administered to genetically obese rats in groups of 8 for 34 days. In addition, standard feed was administered to 7 normal rats for the same period.
なお、飼料及び水は自由に摂取させた。In addition, feed and water were available ad libitum.
第3表 飼料組成
(%)
上記実験飼料を投与後、7日目及び、14日目、21日
目、28日目に7時間の絶食後、尾静脈より採血し、血
清を分離したのち、デクミナーTC−5Cfa和メデッ
クス社製)を用いた酵素法により血清コレステロール値
を測定した。また、飼料投与後、17時間の絶食期間を
経たのち、エーテル麻酔下にて解剖し、血清脂質を同様
に測定した。Table 3 Feed Composition (%) After administering the above experimental feed, blood was collected from the tail vein after a 7-hour fast on the 7th day, 14th day, 21st day, and 28th day, and serum was separated. Serum cholesterol levels were measured by an enzymatic method using Decuminar TC-5Cfa (manufactured by Wamedex Co., Ltd.). After a 17-hour fasting period after administration of the feed, the animals were dissected under ether anesthesia and serum lipids were measured in the same manner.
この結果を第1図に示す。The results are shown in FIG.
標準飼料を投与した遺伝性肥満ラット(−〇−)は、正
常ラット(−・−)に比べてコレステロール値が大幅に
上昇し、高コレステロール血症を示した。一方遺伝性肥
満ラットにおいて、オーツ麦(−△−)ならびに大麦ガ
ム質飼料区(−ロー−)は、標準飼料区に比べてコレス
テロール値が推計学的処理による有意差の検定が1%と
いう非常に小さい危険率で有意に低い値を示した。Genetically obese rats (-〇-) fed standard feed had significantly increased cholesterol levels and hypercholesterolemia compared to normal rats (-.-). On the other hand, in genetically obese rats, cholesterol levels on oats (-△-) and barley gum diets (-low-) were significantly lower than those on standard diets, with a significant difference of 1% using stochastic processing. showed a significantly lower value with a small risk ratio.
以上の結果から、本物質は高コレステロール血症改善効
果を有すると判断される。From the above results, it is judged that this substance has a hypercholesterolemia improving effect.
さらに、解剖を行い、肝臓と脂肪組織を摘出し、3
重量を測定したのち、肝臓中の脂質を抽出し、コレステ
ロール値を上記方法で、トリグリセリド値をトリグリセ
ライドテスト・ワコー(和光純薬社製)を用いたアセチ
ルアセトン発色法により測定した。Furthermore, an autopsy is performed, the liver and adipose tissue are removed, and the weight is measured.The lipids in the liver are extracted, the cholesterol level is measured using the above method, and the triglyceride level is measured using the Triglyceride Test Wako (manufactured by Wako Pure Chemical Industries, Ltd.). It was measured by the acetylacetone color method using .
その結果を第4表に示す。The results are shown in Table 4.
5
6
標準飼料を投与した遺伝性肥満ラットは、正常ラットに
比べて、体重増加、過食、肝臓肥大〔脂肪肝〕、体脂肪
蓄積(肥満)が認められた。一方、遺伝性肥満ラットに
おいては第4表に示すように、オーツ麦ならびに大麦ガ
ム質飼料区は、標準飼料区に比べて肝臓重量ならびに肝
臓中のコレステロール量及びトリグリセリド量が50〜
60%と低い値を示し、推計学的処理による有意差の検
定が1%という非常に小さい危険率で有意差が認められ
た。5 6 Genetically obese rats administered the standard diet exhibited weight gain, overeating, liver enlargement (fatty liver), and body fat accumulation (obesity) compared to normal rats. On the other hand, in genetically obese rats, as shown in Table 4, the oat and barley gummy diets had lower liver weights and liver cholesterol and triglyceride levels by 50 to 50% compared to the standard diets.
It showed a low value of 60%, and a significant difference test using stochastic processing revealed a significant difference with a very small risk rate of 1%.
以上の結果から、本発明の穀類ガム質は強力な脂肪肝抑
制効果を有すると判断された。From the above results, it was determined that the cereal gum of the present invention has a strong fatty liver suppressing effect.
災庭桝又
実施例1で得られたオーツ麦ガム質粉末及び大麦ガム質
粉末各100gにβ−グルタミン酸ソーダ1gをそれぞ
れ混合して脂質代謝改善食品添加物を調製した。100 g each of the oat gum powder and the barley gum powder obtained in Example 1 were mixed with 1 g of sodium β-glutamate to prepare a food additive for improving lipid metabolism.
この食品添加物は、炊飯時の米飯に約2%程度添加する
。Approximately 2% of this food additive is added to cooked rice during cooking.
発1Fυ九果
本発明の穀物ガム質は、脂質代謝改善作用を有するので
、これを有効成分とする脂質代謝改善食品添加物として
用いることができる。そして、この食品添加物は、薬剤
の投与によって脂質代謝を急激に緩和するのではなく、
食事中に少量配合することによってゆるやかに緩和する
ことができる。Since the grain gum of the present invention has a lipid metabolism improving effect, it can be used as a lipid metabolism improving food additive containing it as an active ingredient. In addition, this food additive does not suddenly alleviate lipid metabolism by administering a drug, but rather
It can be gradually relieved by adding a small amount to your meals.
また、本発明の製造法によると、前記穀物ガム質を効率
よく摂取することができる。Furthermore, according to the production method of the present invention, the grain gum can be ingested efficiently.
第1図は、試験例に示す正常ラット及び遺伝性肥満ラッ
トを標準飼料及び穀物ガム質添加飼料で飼育したときの
血清コレステロール値の変化を示す(−・−は正常ラッ
トの標準飼料区を、−〇は遺伝性肥満ラットの標準飼料
区を示す。−△は遺伝性肥満ラットのオーツ麦・ガム質
飼料区を、ローは遺伝性肥満ラットの大麦・ガム質飼料
区を示す)。Figure 1 shows changes in serum cholesterol levels when normal rats and genetically obese rats shown in the test example were fed standard feed and grain-gum supplemented feed (-・- indicates the standard feed group for normal rats; -〇 indicates a standard diet for genetically obese rats. -△ indicates an oat/gum diet for genetically obese rats, and row indicates a barley/gum diet for genetically obese rats).
Claims (5)
にして蛋白質を沈澱除去したのち、残液にアルコールを
加えて沈澱あるいは、脱塩後、乾燥させて得ることがで
きるβ−グルカンを主成分とする下記性質を有する穀物
ガム質 [1]重量平均分子量:10万〜100万 [2]糖組成:グルコース70重量%以上(β−グルカ
ン60重量%以上) アラビノース2〜15重量% キシロース2〜15重量% マンノース、ガラクトース、 ウロン酸(微量) [3]溶解性:水、アルカリ、酸水溶液にそれぞれ可溶
。アセトン、ベンゼン、アルコール、含水アルコール、
クロロホルムにそれぞれ不溶。 [4]塩基性、酸性、中性の区別:中性 [5]性状:白色ないし淡褐色。無味、無臭(1) Extract grains with an alkaline aqueous solution, acidify the extract to remove proteins by precipitation, and then add alcohol to the remaining solution to precipitate or desalt and dry to obtain β-glucan. Cereal gum having the following properties as ingredients [1] Weight average molecular weight: 100,000 to 1,000,000 [2] Sugar composition: Glucose 70% by weight or more (β-glucan 60% by weight or more) Arabinose 2-15% by weight Xylose 2 ~15% by weight Mannose, galactose, uronic acid (trace amounts) [3] Solubility: Soluble in water, alkali, and acid aqueous solutions. Acetone, benzene, alcohol, hydroalcohol,
Insoluble in chloroform. [4] Basic, acidic, neutral: Neutral [5] Properties: White to light brown. Tasteless, odorless
なる群から選択された1種または数種である請求項(1
)の穀物ガム質(2) Claim (1) in which the grain is one or more types selected from the group consisting of wheat, that is, oats, barley, etc.
) grain gum quality
分とする脂質代謝改善物(3) Lipid metabolism improving product containing the grain gum of claim (1) or (2) as an active ingredient
ものである請求項(3)の脂質代謝改善物(4) The lipid metabolism improving product according to claim (3), which improves the symptoms of genetically expressed lipid metabolism abnormality.
出液を除蛋白処理して蛋白質を除いたのち、残存する残
液にアルコールを加えて沈澱あるいは、分画分子量数万
の限外濾過、電気透析、イオン交換樹脂のいずれかによ
って脱塩後、乾燥させて採取することを特徴とするβ−
グルカンを主成分とする下記性質を有する穀物ガム質の
製造法 [1]重量平均分子量:10万〜100万 [2]糖組成:グルコース70重量%以上 (β−グルカン60重量%以上) アラビノース2〜15重量% キシロース2〜15重量% マンノース、ガラクトース、 ウロン酸(微量) [3]溶解性:水、アルカリ、酸水溶液にそれぞれ可溶
。アセトン、ベンゼン、アルコール、含水アルコール、
クロロホルムにそれぞれ不溶。 [4]塩基性、酸性、中性の区別:中性 [5]性状:白色ないし淡褐色。無味、無臭(5) After extracting the grains with an alkaline aqueous solution and removing proteins by deproteinizing the resulting extract, adding alcohol to the remaining liquid for precipitation, or ultrafiltration with a molecular weight cut-off of tens of thousands; β-, which is characterized by being desalted by either electrodialysis or ion exchange resin and then dried and collected.
Method for producing grain gum having the following properties mainly composed of glucan [1] Weight average molecular weight: 100,000 to 1,000,000 [2] Sugar composition: Glucose 70% by weight or more (β-glucan 60% by weight or more) Arabinose 2 ~15% by weight Xylose 2~15% by weight Mannose, galactose, uronic acid (trace amounts) [3] Solubility: Soluble in water, alkali, and acid aqueous solutions. Acetone, benzene, alcohol, hydroalcohol,
Insoluble in chloroform. [4] Basic, acidic, neutral: Neutral [5] Properties: White to light brown. Tasteless, odorless
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2083766A JPH0683652B2 (en) | 1990-03-30 | 1990-03-30 | Lipid metabolism-improved product and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2083766A JPH0683652B2 (en) | 1990-03-30 | 1990-03-30 | Lipid metabolism-improved product and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03285653A true JPH03285653A (en) | 1991-12-16 |
JPH0683652B2 JPH0683652B2 (en) | 1994-10-26 |
Family
ID=13811708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2083766A Expired - Fee Related JPH0683652B2 (en) | 1990-03-30 | 1990-03-30 | Lipid metabolism-improved product and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0683652B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006057406A1 (en) | 2004-11-29 | 2006-06-01 | Suntory Limited | Intraoral pungent substance |
WO2007069733A1 (en) * | 2005-12-16 | 2007-06-21 | Dna Bank Co., Ltd. | Method for production of ceramide-related substance using aqueous alkaline solution and apparatus for the production |
US7566470B2 (en) | 2000-09-27 | 2009-07-28 | Governors Of The University Of Alberta, The | Grain fractionation methods and products |
JP2009263655A (en) * | 2008-03-31 | 2009-11-12 | Adeka Corp | beta-GLUCAN COMPOSITION |
JP2012034582A (en) * | 2010-08-03 | 2012-02-23 | Sapporo Breweries Ltd | Method for producing syrup |
CZ304017B6 (en) * | 2011-05-12 | 2013-08-21 | Jihoceská univerzita v Ceských Budejovicích, Zemedelská fakulta | Method of and apparatus for treatment of barley |
WO2014133060A1 (en) * | 2013-03-01 | 2014-09-04 | 株式会社林原 | Agent for lifestyle-related disease and oral composition comprising same |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002097203A (en) * | 2000-09-22 | 2002-04-02 | Asahi Denka Kogyo Kk | METHOD FOR EXTRACTING beta-GLUCAN |
JP4711497B2 (en) * | 2000-09-28 | 2011-06-29 | 株式会社Adeka | β-glucan extraction promoter |
JP4688335B2 (en) * | 2001-04-10 | 2011-05-25 | 株式会社Adeka | Dough for bakery products |
JP4698038B2 (en) * | 2001-02-15 | 2011-06-08 | 株式会社Adeka | Bakery products containing oil composition containing β-glucan |
JP4964710B2 (en) * | 2007-08-29 | 2012-07-04 | 群栄化学工業株式会社 | Process for producing β-glucan-containing cereal saccharified product |
JP5985146B2 (en) | 2010-10-27 | 2016-09-06 | 国立大学法人埼玉大学 | Cereal powder and applied food |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5841824A (en) * | 1981-09-07 | 1983-03-11 | Nippon Shokuhin Kako Kk | Inhibitory substance for rise in blood serumal cholesterol |
JPS60202824A (en) * | 1984-03-28 | 1985-10-14 | Nitto Seifun Kk | Production of health food |
-
1990
- 1990-03-30 JP JP2083766A patent/JPH0683652B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5841824A (en) * | 1981-09-07 | 1983-03-11 | Nippon Shokuhin Kako Kk | Inhibitory substance for rise in blood serumal cholesterol |
JPS60202824A (en) * | 1984-03-28 | 1985-10-14 | Nitto Seifun Kk | Production of health food |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7566470B2 (en) | 2000-09-27 | 2009-07-28 | Governors Of The University Of Alberta, The | Grain fractionation methods and products |
WO2006057406A1 (en) | 2004-11-29 | 2006-06-01 | Suntory Limited | Intraoral pungent substance |
WO2007069733A1 (en) * | 2005-12-16 | 2007-06-21 | Dna Bank Co., Ltd. | Method for production of ceramide-related substance using aqueous alkaline solution and apparatus for the production |
JPWO2007069733A1 (en) * | 2005-12-16 | 2009-05-28 | 株式会社ディーエヌエーバンク・リテイル | Method and apparatus for producing ceramide-related substances using alkaline aqueous solution |
JP2009263655A (en) * | 2008-03-31 | 2009-11-12 | Adeka Corp | beta-GLUCAN COMPOSITION |
JP2012034582A (en) * | 2010-08-03 | 2012-02-23 | Sapporo Breweries Ltd | Method for producing syrup |
CZ304017B6 (en) * | 2011-05-12 | 2013-08-21 | Jihoceská univerzita v Ceských Budejovicích, Zemedelská fakulta | Method of and apparatus for treatment of barley |
WO2014133060A1 (en) * | 2013-03-01 | 2014-09-04 | 株式会社林原 | Agent for lifestyle-related disease and oral composition comprising same |
Also Published As
Publication number | Publication date |
---|---|
JPH0683652B2 (en) | 1994-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60036282T2 (en) | NON-FERMENTED GRAIN FROM PSYLLIUM SEEDS | |
DE60211858T2 (en) | METHOD FOR THE FRACTIONATION OF CEREALS | |
JP2542462B2 (en) | Sugar composition containing soluble fiber | |
JPH03285653A (en) | Fat metabolism improving substance and production thereof | |
JPS58201719A (en) | Biologically active polysaccharide concentrate and manufacture of composition containing same | |
JP2002275076A (en) | Inhibitor of elevation of glycemia and healthy food | |
JP2787252B2 (en) | Colorectal cancer inhibitor | |
CN108359026B (en) | Preparation method and application of water-insoluble xylan | |
JP2002223727A (en) | Functional food | |
KR100288117B1 (en) | Cacao extract including dietary fiber | |
CN112691115A (en) | Arabinoxylan and compound for preventing/treating gastrointestinal mucosa and liver injury | |
JP4368569B2 (en) | Preventive and ameliorating agents for renal function decline | |
JP3459815B2 (en) | Composition having inhibitory action on fatty liver separated from distillation residue of barley shochu and process for producing the composition | |
JP3753305B2 (en) | Composition having fatty liver inhibitory action separated from barley koji and method for producing the composition | |
JP3191956B2 (en) | Alcoholic fatty liver inhibitors | |
EP2936999A1 (en) | Anticholesteremic fibre combination | |
JP2004292382A (en) | Agent for promoting absorption of mineral, and agent for preventing and/or ameliorating osteoporosis | |
JPH0769910A (en) | Composition for improving lipid metabolism and suppressing increase of blood sugar level | |
JPH0678236B2 (en) | Liver function activator | |
JPH0434527B2 (en) | ||
JP2588616B2 (en) | Substance having a blood pressure elevation inhibitory action and food and drink using the same | |
JPH04360835A (en) | Alcoholic hepatopathy-relieving substance | |
JPH01242530A (en) | Fatty liver suppressing substance | |
JP2588617B2 (en) | Cholesterol gallstone formation inhibitor | |
JPS63135334A (en) | Hepatic function activation substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071026 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081026 Year of fee payment: 14 |
|
LAPS | Cancellation because of no payment of annual fees |